首页 > 最新文献

Journal of Medical Biochemistry最新文献

英文 中文
The relationship between lactate dehydrogenase and apolipoprotein A1 levels in patients with severe pneumonia 重症肺炎患者乳酸脱氢酶与载脂蛋白A1水平的关系
4区 医学 Q4 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2023-11-09 DOI: 10.5937/jomb0-45782
Jiang Wang, Ronghua Wang, Ying Zhou, Yao Ma, Chunyan Xiong
Background: To investigate the relationship between lactate dehydrogenase and apolipoprotein A1 levels and the condition and prognosis of patients with severe pneumonia. Methods: We retrospectively collected 204 patients with severe pneumonia who were hospitalized from January 1, 2019 to December 1, 2021 in our hospital (respiratory intensive care unit (RICU)), and divided into survival group (160 patients) and death group (44 patients) according to their hospitalization outcome. The relationship between lactate dehydrogenase and apolipoprotein A1 levels and general information, disease, and treatment needs of patients with severe pneumonia was analyzed, and lactate dehydrogenase, apolipoprotein A1, neutrophil-to-lymphocyte ratio, hematocrit, C-reactive protein, calcitoninogen, D-dimer, Acute Physiology and Chronic Health Status Rating System II, and Pneumonia Severity Index scores were compared between the survival and death groups. The value of these indicators in determining the prognosis of patients was analyzed using subject operating characteristic (ROC) curves. Logistic regression was used to analyze the risk factors for death from severe pneumonia. Results: The differences were statistically significant (P<0.05) when comparing age and pneumonia typing between the two groups. There was no statistically significant difference between the two groups in terms of gender and total length of stay (P >0.05). There was no statistically significant difference in LDH and ApoA1 levels between male patients and female patients (P>0.05). The differences in LDH and ApoA1 levels were statistically significant (P<0.05) when comparing patients with severe pneumonia at different ages. The differences in LDH and ApoA1 levels between SCAP and SHAP patients were not statistically significant (P>0.05). LDH and ApoA1 levels were higher in patients with severe pneumonia with acute exacerbation of slow-onset lung or MODS during hospitalization than in patients with severe pneumonia without acute exacerbation of slow-onset lung or MODS, with statistically significant differences (P<0.05). The differences were statistically significant (P<0.05) when comparing LDH and ApoA1 levels in patients with severe pneumonia with different PSI grades or APACHE II scores. The differences were statistically significant (P<0.05) when comparing LDH and ApoA1 levels in patients with severe pneumonia with different ICU length of stay. There was no statistically significant difference in LDH and ApoA1 levels when comparing patients with severe pneumonia who required tracheal intubation or sedation and analgesia during hospitalization (P>0.05). LDH and ApoA1 levels in patients with severe pneumonia with different duration of mechanical ventilation were compared with statistically significant differences (P<0.05). LDH and ApoA1 levels in the death group were 105.08 (75.22 ~140.0), which was significantly higher than 86.66 (62.66 ~ 106.14) in the survival group, with statisti
背景:探讨乳酸脱氢酶和载脂蛋白A1水平与重症肺炎患者病情及预后的关系。 方法:回顾性收集2019年1月1日至2021年12月1日在我院(呼吸重症监护室(RICU))住院的204例重症肺炎患者,根据住院结局分为生存组(160例)和死亡组(44例)。分析乳酸脱氢酶、载脂蛋白A1水平与重症肺炎患者一般信息、病情及治疗需求的关系,比较存活组与死亡组乳酸脱氢酶、载脂蛋白A1、中性粒细胞与淋巴细胞比值、血细胞比容、c反应蛋白、降钙素原、d -二聚体、急性生理与慢性健康状态评定系统II、肺炎严重程度指数评分。采用受试者工作特征(ROC)曲线分析这些指标对患者预后的判断价值。采用Logistic回归分析重症肺炎死亡的危险因素。 结果:两组患者年龄、肺炎分型比较差异均有统计学意义(P<0.05)。两组患者性别、总住院时间差异无统计学意义(P >0.05)。男女患者LDH、ApoA1水平差异无统计学意义(P>0.05)。不同年龄重症肺炎患者LDH、ApoA1水平比较差异均有统计学意义(P<0.05)。SCAP与SHAP患者LDH、ApoA1水平差异无统计学意义(P>0.05)。重症肺炎合并慢发性肺或MODS急性加重患者住院期间LDH、ApoA1水平高于未合并慢发性肺或MODS急性加重的重症肺炎患者,差异有统计学意义(P<0.05)。不同PSI分级或APACHEⅱ评分的重症肺炎患者LDH和ApoA1水平比较,差异均有统计学意义(P<0.05)。不同ICU住院时间重症肺炎患者LDH、ApoA1水平比较差异有统计学意义(P<0.05)。与住院期间需要气管插管或镇静镇痛的重症肺炎患者相比,LDH和ApoA1水平差异无统计学意义(P>0.05)。不同机械通气时间的重症肺炎患者LDH、ApoA1水平比较差异有统计学意义(P<0.05)。死亡组LDH、ApoA1水平为105.08(75.22 ~140.0),显著高于生存组86.66(62.66 ~ 106.14),差异有统计学意义(P<0.05)。两组患者NLR、HCT、CRP、PCT、DD、PSI评分、APACHE II评分比较,差异均无统计学意义(P>0.05)。LDH预测重症肺炎患者死亡的AUC为0.723 (95% CI(0.579 ~ 0.868)),敏感性为70.7%,特异性为71.8%,临界值为289 U/mL; ApoA1预测重症肺炎患者死亡的AUC为0.754 (95% CI(0.616 ~ 0.891)),临界值为0.92 mg/mL,敏感性为72.2%,特异性为73.1%。LDH联合ApoA1预测重症肺炎患者死亡的AUC为0.873 (95% CI(0.779 ~ 0.967)),线下面积高于单独检测,灵敏度为85.14%,特异性为82.83%。多因素二分类logistic回归分析显示,LDH>289 U/mL和ApoA1<0.92 mg/mL会增加重症肺炎死亡风险,差异有统计学意义(OR=4.275、0.548,P<0.05)。& # x0D;结论:重症肺炎患者LDH水平升高、ApoA1水平降低对评估患者病情及预后有重要价值,可为早期评估患者病情及诊治提供帮助。
{"title":"The relationship between lactate dehydrogenase and apolipoprotein A1 levels in patients with severe pneumonia","authors":"Jiang Wang, Ronghua Wang, Ying Zhou, Yao Ma, Chunyan Xiong","doi":"10.5937/jomb0-45782","DOIUrl":"https://doi.org/10.5937/jomb0-45782","url":null,"abstract":"Background: To investigate the relationship between lactate dehydrogenase and apolipoprotein A1 levels and the condition and prognosis of patients with severe pneumonia.&#x0D; Methods: We retrospectively collected 204 patients with severe pneumonia who were hospitalized from January 1, 2019 to December 1, 2021 in our hospital (respiratory intensive care unit (RICU)), and divided into survival group (160 patients) and death group (44 patients) according to their hospitalization outcome. The relationship between lactate dehydrogenase and apolipoprotein A1 levels and general information, disease, and treatment needs of patients with severe pneumonia was analyzed, and lactate dehydrogenase, apolipoprotein A1, neutrophil-to-lymphocyte ratio, hematocrit, C-reactive protein, calcitoninogen, D-dimer, Acute Physiology and Chronic Health Status Rating System II, and Pneumonia Severity Index scores were compared between the survival and death groups. The value of these indicators in determining the prognosis of patients was analyzed using subject operating characteristic (ROC) curves. Logistic regression was used to analyze the risk factors for death from severe pneumonia.&#x0D; Results: The differences were statistically significant (P&lt;0.05) when comparing age and pneumonia typing between the two groups. There was no statistically significant difference between the two groups in terms of gender and total length of stay (P &gt;0.05). There was no statistically significant difference in LDH and ApoA1 levels between male patients and female patients (P&gt;0.05). The differences in LDH and ApoA1 levels were statistically significant (P&lt;0.05) when comparing patients with severe pneumonia at different ages. The differences in LDH and ApoA1 levels between SCAP and SHAP patients were not statistically significant (P&gt;0.05). LDH and ApoA1 levels were higher in patients with severe pneumonia with acute exacerbation of slow-onset lung or MODS during hospitalization than in patients with severe pneumonia without acute exacerbation of slow-onset lung or MODS, with statistically significant differences (P&lt;0.05). The differences were statistically significant (P&lt;0.05) when comparing LDH and ApoA1 levels in patients with severe pneumonia with different PSI grades or APACHE II scores. The differences were statistically significant (P&lt;0.05) when comparing LDH and ApoA1 levels in patients with severe pneumonia with different ICU length of stay. There was no statistically significant difference in LDH and ApoA1 levels when comparing patients with severe pneumonia who required tracheal intubation or sedation and analgesia during hospitalization (P&gt;0.05). LDH and ApoA1 levels in patients with severe pneumonia with different duration of mechanical ventilation were compared with statistically significant differences (P&lt;0.05). LDH and ApoA1 levels in the death group were 105.08 (75.22 ~140.0), which was significantly higher than 86.66 (62.66 ~ 106.14) in the survival group, with statisti","PeriodicalId":16175,"journal":{"name":"Journal of Medical Biochemistry","volume":" 21","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135286390","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Red blood cell distribution width (RDW) is a significant predictor of survival in laryngeal cancer patients: Systematic literature review and meta-analysis. 红细胞分布宽度(RDW)是预测喉癌患者生存期的重要指标:系统文献综述和荟萃分析。
IF 2.5 4区 医学 Q4 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2023-10-27 DOI: 10.5937/jomb0-42947
Riccardo Nocini, Fabian Sanchis-Gomar, Giuseppe Lippi, Camilla Mattiuzzi

Background: This systematic literature review and meta-analysis investigated whether the red blood cell distribution (RDW) may predict survival outcomes in laryngeal cancer patients undergoing curative treatment.

Methods: We conducted an electronic search in Medline and Scopus using the keywords "red blood cell distribution width" OR "RDW" AND "laryngeal cancer" OR "larynx cancer" OR "laryngeal carcinoma" OR "larynx carcinoma," without time or language restrictions (up to February 2023), for identifying studies investigating the prognostic value of RDW in patients with any form of laryngeal cancer and with a primary endpoint that was set as survival rate and/or disease-free survival between 1 and 10 years after curative treatment. The research was conducted according to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) 2020 reporting checklist.

背景:这项系统性文献综述和荟萃分析研究了红细胞分布(RDW)是否可以预测接受根治性治疗的喉癌患者的生存结果:这项系统性文献综述和荟萃分析研究了红细胞分布(RDW)是否可以预测接受根治性治疗的喉癌患者的生存结果:我们使用关键词 "红细胞分布宽度 "或 "RDW"和 "喉癌 "或 "喉癌 "或 "喉癌 "或 "喉癌",不受时间或语言限制(截至 2023 年 2 月),以确定调查 RDW 对任何形式喉癌患者预后价值的研究,研究的主要终点设定为治愈性治疗后 1-10 年间的生存率和/或无病生存率。这项研究是根据PRISMA(系统综述和Meta分析首选报告项目)2020报告清单进行的。
{"title":"Red blood cell distribution width (RDW) is a significant predictor of survival in laryngeal cancer patients: Systematic literature review and meta-analysis.","authors":"Riccardo Nocini, Fabian Sanchis-Gomar, Giuseppe Lippi, Camilla Mattiuzzi","doi":"10.5937/jomb0-42947","DOIUrl":"10.5937/jomb0-42947","url":null,"abstract":"<p><strong>Background: </strong>This systematic literature review and meta-analysis investigated whether the red blood cell distribution (RDW) may predict survival outcomes in laryngeal cancer patients undergoing curative treatment.</p><p><strong>Methods: </strong>We conducted an electronic search in Medline and Scopus using the keywords \"red blood cell distribution width\" OR \"RDW\" AND \"laryngeal cancer\" OR \"larynx cancer\" OR \"laryngeal carcinoma\" OR \"larynx carcinoma,\" without time or language restrictions (up to February 2023), for identifying studies investigating the prognostic value of RDW in patients with any form of laryngeal cancer and with a primary endpoint that was set as survival rate and/or disease-free survival between 1 and 10 years after curative treatment. The research was conducted according to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) 2020 reporting checklist.</p>","PeriodicalId":16175,"journal":{"name":"Journal of Medical Biochemistry","volume":"1 1","pages":"557-564"},"PeriodicalIF":2.5,"publicationDate":"2023-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10712959/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81512355","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of screening indicators for different types of thalassemia carriers in Hunan Province 湖南省不同类型地中海贫血携带者筛查指标的比较
4区 医学 Q4 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2023-10-25 DOI: 10.5937/jomb0-46085
Hua Tang, Rong Yu, ZiYin Yu, Hui Xi
Backgroud: Carrier screening is the most effective method to block the occurrence of thalassemia. However, due to differences in race and genotype, MCV, MCH, HbA2 and other indicators are far from each other. The purpose of this study is to evaluate the common screening indicators of α, β and αβ-compound thalassemia carriers in Hunan Province, and try to use the relevant formulas in the existing literature to predict and distinguish different types of thalassemia carriers. Methods: Receiver operating characteristic curve (ROC curve) combined with Youden index was utilized to analyze results of blood routine examination, hemoglobin electrophoresis, and literature-related formulas for 1111 α-thalassemia carriers, 464 β-thalassemia carriers and 24 αβ-thalassemia carriers. Results: For α-thalassemia carriers, no matter which screening index or formula, the screening efficiency was not ideal. For β-thalassemia minor carriers, RBC, RDW_CV, Hb_A2, Hb_F and formula 5-7 could be used, and for compound thalassemia, RBC, RDW_CV, Hb_A2 and formula 5-6 are suitable. Hb_A2 has high efficiency in the screening of β-thalassemia minor and αβ-thalassemia. For the screening of β-thalassemia minor, if the cut-off value of HbA2 is set to 3%, the detection rate of 93.32% can be obtained at the positive rate of 9.6%, and if it is set to 3.15%, the detection rate can also reach 81.68% at the positive rate of 2.89%. For αβ-thalassemia, if the cut-off value of HbA2 is set to 3%, the detection rate of 95.83% can be obtained under the positive rate of 8.08%. Conclusions: Different screening indicators and formulas have different efficiencies for different thalassemia carriers. α-thalassemia carriers are easily missed by screening indicators or corresponding formulas. HbA2 is a better screening indicator for both β-thalassemia minor carriers and αβ-thalassemia carriers, and formulas 5, 6, and 7 are suitable for β-thalassemia minor carriers, and formulas 5 and 6 are better for αβ-thalassemia carriers. To fully and objectively understand each screening index, data support has been provided for clinical and laboratory tests.
背景:携带者筛查是阻断地中海贫血发生的最有效方法。然而,由于种族和基因型的差异,MCV、MCH、HbA2等指标相距甚远。本研究的目的是评价湖南省α、β和αβ-复合地中海贫血携带者的常用筛查指标,并尝试利用现有文献中的相关公式预测和区分不同类型的地中海贫血携带者。 方法:采用受试者工作特征曲线(ROC曲线)结合约登指数对1111例α-地中海贫血携带者、464例α-地中海贫血携带者和24例α-地中海贫血携带者的血常规检查结果、血红蛋白电泳及文献相关公式进行分析。结果:对于α-地中海贫血携带者,无论采用何种筛选指标或配方,筛选效果都不理想。对于β-地中海贫血轻微携带者,可采用RBC、RDW_CV、Hb_A2、Hb_F和配方5-7;对于复合地中海贫血,可采用RBC、RDW_CV、Hb_A2和配方5-6。Hb_A2对β-轻微地中海贫血和αβ-地中海贫血的筛查效率高。对于β-轻微地中海贫血的筛查,将HbA2的临界值设为3%,在9.6%的阳性率下可获得93.32%的检出率,将HbA2的临界值设为3.15%,在2.89%的阳性率下,检出率也可达到81.68%。αβ-地中海贫血,将HbA2的临界值设为3%,在阳性率为8.08%的情况下,可获得95.83%的检出率。 结论:不同筛选指标和配方对不同地中海贫血携带者的筛查效果不同。α-地中海贫血携带者很容易被筛选指标或相应的公式遗漏。HbA2对于β-轻微地中海贫血携带者和αβ-地中海贫血携带者都是较好的筛选指标,其中式5、6、7适用于β-轻微地中海贫血携带者,式5、6适用于αβ-轻微地中海贫血携带者。为全面客观地了解各项筛查指标,为临床和实验室检测提供数据支持。
{"title":"Comparison of screening indicators for different types of thalassemia carriers in Hunan Province","authors":"Hua Tang, Rong Yu, ZiYin Yu, Hui Xi","doi":"10.5937/jomb0-46085","DOIUrl":"https://doi.org/10.5937/jomb0-46085","url":null,"abstract":"Backgroud: Carrier screening is the most effective method to block the occurrence of thalassemia. However, due to differences in race and genotype, MCV, MCH, HbA2 and other indicators are far from each other. The purpose of this study is to evaluate the common screening indicators of α, β and αβ-compound thalassemia carriers in Hunan Province, and try to use the relevant formulas in the existing literature to predict and distinguish different types of thalassemia carriers.&#x0D; Methods: Receiver operating characteristic curve (ROC curve) combined with Youden index was utilized to analyze results of blood routine examination, hemoglobin electrophoresis, and literature-related formulas for 1111 α-thalassemia carriers, 464 β-thalassemia carriers and 24 αβ-thalassemia carriers.&#x0D; Results: For α-thalassemia carriers, no matter which screening index or formula, the screening efficiency was not ideal. For β-thalassemia minor carriers, RBC, RDW_CV, Hb_A2, Hb_F and formula 5-7 could be used, and for compound thalassemia, RBC, RDW_CV, Hb_A2 and formula 5-6 are suitable. Hb_A2 has high efficiency in the screening of β-thalassemia minor and αβ-thalassemia. For the screening of β-thalassemia minor, if the cut-off value of HbA2 is set to 3%, the detection rate of 93.32% can be obtained at the positive rate of 9.6%, and if it is set to 3.15%, the detection rate can also reach 81.68% at the positive rate of 2.89%. For αβ-thalassemia, if the cut-off value of HbA2 is set to 3%, the detection rate of 95.83% can be obtained under the positive rate of 8.08%.&#x0D; Conclusions: Different screening indicators and formulas have different efficiencies for different thalassemia carriers. α-thalassemia carriers are easily missed by screening indicators or corresponding formulas. HbA2 is a better screening indicator for both β-thalassemia minor carriers and αβ-thalassemia carriers, and formulas 5, 6, and 7 are suitable for β-thalassemia minor carriers, and formulas 5 and 6 are better for αβ-thalassemia carriers. To fully and objectively understand each screening index, data support has been provided for clinical and laboratory tests.","PeriodicalId":16175,"journal":{"name":"Journal of Medical Biochemistry","volume":"33 9","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135169371","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Clinical significance of serum synaptophysin like 1 protein levels in breast cancer 乳腺癌患者血清突触素样1蛋白水平的临床意义
4区 医学 Q4 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2023-10-22 DOI: 10.5937/jomb0-46198
Hafize Uzun, Yagmur Ozge Turac Kosem, Mehmet Velidedeoglu, Pınar Kocael, Seyma Dumur, Osman Simsek
Background: Mammography, used for breast cancer (BC) screening, has limitations such as decreased sensitivity in dense breasts. Currently used tumor markers are insufficient in diagnosing breast cancer. In this study, we aimed to investigate the relationship between serum levels of synaptophysin-like protein 1 (SYPL1) and BC, as well as compare SYPL1 with other blood tumor markers. Method: The study group consisted of 80 female patients with a histopathological diagnosis of invasive BC and didn’t receive any radiotherapy/chemotherapy. The control group 72 women with noprevious history of breast disease and evaluated as Breast Imaging Reporting and Data Systems (BI-RADS 1-2) on imaging. Serum SYPL1, cancer antigen 15-3 (CA 15-3) and carcinoembryonic antigen (CEA) were measured in both groups. Results: The diagnostic values of SYPL1, CEA and CA15-3 proteins in diagnosing BC were statistically significant. The sensitivity of SYPL1 was 48.75%, with a specificity of 80.56%. CA15-3 had a sensitivity of 80% and a specificity of 49.30%. There wasn’t statistically significant correlation between serum SYPL1 and tumor diameter, lymph node metastasis, distant organ metastasis, and stage. Conclusion: The serum SYPL1 maintained a higher discriminatory ability for BC. The serum SYPL1 level can be used with high specificity in the diagnosis of BC. Although SYPL1 has low diagnostic value in BC by itself.
背景:乳房x线摄影,用于乳腺癌筛查,有局限性,如在致密乳房敏感性降低。目前使用的肿瘤标志物对乳腺癌的诊断不足。在本研究中,我们旨在探讨血清突触素样蛋白1 (SYPL1)水平与BC的关系,并将SYPL1与其他血液肿瘤标志物进行比较。方法:研究组80例经组织病理学诊断为浸润性BC的女性患者,未接受任何放疗/化疗。对照组为72名既往无乳腺疾病病史的女性,采用乳腺影像学报告和数据系统(BI-RADS 1-2)进行影像学评估。检测两组患者血清SYPL1、癌抗原15-3 (CA 15-3)、癌胚抗原(CEA)水平。结果:SYPL1、CEA、CA15-3蛋白对BC的诊断价值有统计学意义。SYPL1的敏感性为48.75%,特异性为80.56%。CA15-3的敏感性为80%,特异性为49.30%。血清SYPL1与肿瘤直径、淋巴结转移、远处脏器转移、分期无统计学意义。& # x0D;结论:血清SYPL1对BC具有较高的鉴别能力。血清SYPL1水平可作为诊断BC的高特异性指标。虽然SYPL1本身对BC的诊断价值较低。
{"title":"The Clinical significance of serum synaptophysin like 1 protein levels in breast cancer","authors":"Hafize Uzun, Yagmur Ozge Turac Kosem, Mehmet Velidedeoglu, Pınar Kocael, Seyma Dumur, Osman Simsek","doi":"10.5937/jomb0-46198","DOIUrl":"https://doi.org/10.5937/jomb0-46198","url":null,"abstract":"Background: Mammography, used for breast cancer (BC) screening, has limitations such as decreased sensitivity in dense breasts. Currently used tumor markers are insufficient in diagnosing breast cancer. In this study, we aimed to investigate the relationship between serum levels of synaptophysin-like protein 1 (SYPL1) and BC, as well as compare SYPL1 with other blood tumor markers. Method: The study group consisted of 80 female patients with a histopathological diagnosis of invasive BC and didn’t receive any radiotherapy/chemotherapy. The control group 72 women with noprevious history of breast disease and evaluated as Breast Imaging Reporting and Data Systems (BI-RADS 1-2) on imaging. Serum SYPL1, cancer antigen 15-3 (CA 15-3) and carcinoembryonic antigen (CEA) were measured in both groups. Results: The diagnostic values of SYPL1, CEA and CA15-3 proteins in diagnosing BC were statistically significant. The sensitivity of SYPL1 was 48.75%, with a specificity of 80.56%. CA15-3 had a sensitivity of 80% and a specificity of 49.30%. There wasn’t statistically significant correlation between serum SYPL1 and tumor diameter, lymph node metastasis, distant organ metastasis, and stage. &#x0D; Conclusion: The serum SYPL1 maintained a higher discriminatory ability for BC. The serum SYPL1 level can be used with high specificity in the diagnosis of BC. Although SYPL1 has low diagnostic value in BC by itself.","PeriodicalId":16175,"journal":{"name":"Journal of Medical Biochemistry","volume":"11 3","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135462193","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Roles of MIR155HG and TNF-α in Evaluation of Prognosis of Patients with Systemic Lupus Erythematosus MIR155HG和TNF-α在评价系统性红斑狼疮患者预后中的作用
4区 医学 Q4 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2023-10-22 DOI: 10.5937/jomb0-45870
Xiaojing Gu, Hu Chen, Rongping Li, Dibin Guo
Background: To study the roles of micro ribonucleic acid (miR)-155 host gene (MIR155HG) and tumor necrosis factor-α (TNF-α) in the evaluation of prognosis of patients with systemic lupus erythematosus (SLE). Methods: A total of 130 patients with SLE admitted to our hospital were selected, and the SLE disease activity index (SLEDAI) score was given. The expressions of MIR155HG and TNF-α were detected via quantitative reverse transcription-polymerase chain reaction (qRT-PCR), the incidence of complications during treatment was observed, and the associations of MIR155HG and TNF-α with SLEDAI before treatment and complications were analyzed. All patients were followed up after discharge, and the related factors to the prognosis of patients were analyzed via Cox regression analysis. Results: The levels of MIR155HG and TNF-α were higher in patients with an SLEDAI score of 10-14 points than those in patients with an SLEDAI score of 5-9 points and 0-4 points. MIR155HG and TNF-α were positively correlated with the incidence of infection, renal damage and cardiac damage. Moreover, there was also a positive correlation between the expressions of serum MIR155HG and TNF-α in SLE patients. SLEDAI score ≥10 points, complications during hospitalization, and highly-expressed MIR155HG and TNF-α were risk factors related to the prognosis of patients. Conclusion: MIR155HG and TNF-α are key regulators in the pathogenesis of SLE, and they can affect the prognosis of patients. Such a finding provides potential new targets for the treatment of SLE.
背景:研究微核糖核酸(miR)-155宿主基因(MIR155HG)和肿瘤坏死因子-α (TNF-α)在评价系统性红斑狼疮(SLE)患者预后中的作用。 方法:选取我院收治的SLE患者130例,给予SLE疾病活动性指数(SLEDAI)评分。采用定量逆转录聚合酶链反应(qRT-PCR)检测MIR155HG、TNF-α的表达,观察治疗过程中并发症的发生情况,分析治疗前MIR155HG、TNF-α与SLEDAI及并发症的相关性。所有患者出院后均进行随访,通过Cox回归分析影响患者预后的相关因素。 结果:SLEDAI评分为10-14分的患者MIR155HG和TNF-α水平高于SLEDAI评分为5-9分和0-4分的患者。MIR155HG、TNF-α与感染发生率、肾损害发生率、心脏损害发生率呈正相关。此外,SLE患者血清MIR155HG与TNF-α的表达也存在正相关。SLEDAI评分≥10分、住院期间并发症、MIR155HG、TNF-α高表达是影响患者预后的危险因素。 结论:MIR155HG和TNF-α是SLE发病的关键调控因子,影响患者预后。这一发现为SLE的治疗提供了潜在的新靶点。
{"title":"Roles of MIR155HG and TNF-α in Evaluation of Prognosis of Patients with Systemic Lupus Erythematosus","authors":"Xiaojing Gu, Hu Chen, Rongping Li, Dibin Guo","doi":"10.5937/jomb0-45870","DOIUrl":"https://doi.org/10.5937/jomb0-45870","url":null,"abstract":"Background: To study the roles of micro ribonucleic acid (miR)-155 host gene (MIR155HG) and tumor necrosis factor-α (TNF-α) in the evaluation of prognosis of patients with systemic lupus erythematosus (SLE).&#x0D; Methods: A total of 130 patients with SLE admitted to our hospital were selected, and the SLE disease activity index (SLEDAI) score was given. The expressions of MIR155HG and TNF-α were detected via quantitative reverse transcription-polymerase chain reaction (qRT-PCR), the incidence of complications during treatment was observed, and the associations of MIR155HG and TNF-α with SLEDAI before treatment and complications were analyzed. All patients were followed up after discharge, and the related factors to the prognosis of patients were analyzed via Cox regression analysis.&#x0D; Results: The levels of MIR155HG and TNF-α were higher in patients with an SLEDAI score of 10-14 points than those in patients with an SLEDAI score of 5-9 points and 0-4 points. MIR155HG and TNF-α were positively correlated with the incidence of infection, renal damage and cardiac damage. Moreover, there was also a positive correlation between the expressions of serum MIR155HG and TNF-α in SLE patients. SLEDAI score ≥10 points, complications during hospitalization, and highly-expressed MIR155HG and TNF-α were risk factors related to the prognosis of patients.&#x0D; Conclusion: MIR155HG and TNF-α are key regulators in the pathogenesis of SLE, and they can affect the prognosis of patients. Such a finding provides potential new targets for the treatment of SLE.","PeriodicalId":16175,"journal":{"name":"Journal of Medical Biochemistry","volume":"49 2","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135462194","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Determination of systemic inflamatory biomarkers in multiple sclerosis 多发性硬化症中系统性炎症生物标志物的测定
4区 医学 Q4 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2023-10-20 DOI: 10.5937/jomb0-45083
Maša Todorović, Stanislava Nikolić, Željko Živanović, Svetlana Simić, Lorand Sakalaš, Igor Spasić, Branislava Ilinčić, Velibor Čabarkapa
Background: Multiple sclerosis is one of the most common demyelinating diseases of the central nervous system. We aimed to investigate serum and cerebrospinal fluid levels of different laboratory inflammatory biomarkers in patients with MS. Methods: A total of 120 subjects participated in the study, 60 of whom are diagnosed with MS, 30 with the final diagnose of non-inflammatory diseases of the CNS, and 30 healthy subjects representing the control group. Regarding to progression of radiological findings after 2 years from the initial diagnosis, MS group was divided into subgroups: with stationary radiological findings (n=30) and with radiologically proven disease progression (n=30). In all patients we analyzed levels of laboratory inflammatory biomarkers: CRP, NLR, GDF15 and NFs. Values of NFs and GDF15 were analyzed initial while the values of CRP and NLR were analyzed initial and after two years. Results: We found statistically lower GDF15 values and initial CRP values in MS group in regards to group with non-inflammatory diseases of the CNS (p=0.000). On the other side, we determined significant elevation of laboratory markers CRP and NLR, initial and after two years period, in MS subgroup with progression of MRI findings (p= 0.000 and p=0.050, respectively). Also we found a positive correlation of CRP and neurofilaments (r=0.243, p=0.04), as well as a positive correlation of CRP and GDF15 in patients with MS (r=0.769, p=0.000). Conclusion: We found significant elevation of laboratory markers of systemic inflammation, CRP and NLR in MS patients who developed disease progression based on MRI findings. Key words: Multiple sclerosis; Neutrophil to lymphocyte ratio; C reactive protein, Neurofilaments, Growth differentiation factor 15
背景:多发性硬化症是最常见的中枢神经系统脱髓鞘疾病之一。我们旨在研究多发性硬化症患者血清和脑脊液中不同实验室炎症生物标志物的水平。方法:共120名受试者参与研究,其中60名诊断为MS, 30名最终诊断为中枢神经系统非炎症性疾病,30名健康受试者作为对照组。根据首次诊断2年后影像学表现的进展情况,MS组分为影像学表现稳定(n=30)和影像学证实疾病进展(n=30)两组。在所有患者中,我们分析了实验室炎症生物标志物的水平:CRP、NLR、GDF15和nf。分析两组患者初始时的NFs和GDF15值,同时分析两年后的CRP和NLR值。 结果:MS组GDF15值和初始CRP值较CNS非炎症性疾病组明显降低(p=0.000)。另一方面,我们发现,随着MRI表现的进展,MS亚组的实验室标志物CRP和NLR在最初和两年后显著升高(p= 0.000和p=0.050分别)。我们还发现,MS患者CRP与神经丝呈正相关(r=0.243, p=0.04), CRP与GDF15呈正相关(r=0.769, p=0.000)。 结论:我们发现,在MRI表现为疾病进展的MS患者中,全身性炎症、CRP和NLR的实验室标志物显著升高。关键词:多发性硬化症;中性粒细胞与淋巴细胞比值;C反应蛋白,神经丝,生长分化因子15
{"title":"Determination of systemic inflamatory biomarkers in multiple sclerosis","authors":"Maša Todorović, Stanislava Nikolić, Željko Živanović, Svetlana Simić, Lorand Sakalaš, Igor Spasić, Branislava Ilinčić, Velibor Čabarkapa","doi":"10.5937/jomb0-45083","DOIUrl":"https://doi.org/10.5937/jomb0-45083","url":null,"abstract":"Background: Multiple sclerosis is one of the most common demyelinating diseases of the central nervous system. We aimed to investigate serum and cerebrospinal fluid levels of different laboratory inflammatory biomarkers in patients with MS.&#x0D; Methods: A total of 120 subjects participated in the study, 60 of whom are diagnosed with MS, 30 with the final diagnose of non-inflammatory diseases of the CNS, and 30 healthy subjects representing the control group. Regarding to progression of radiological findings after 2 years from the initial diagnosis, MS group was divided into subgroups: with stationary radiological findings (n=30) and with radiologically proven disease progression (n=30). In all patients we analyzed levels of laboratory inflammatory biomarkers: CRP, NLR, GDF15 and NFs. Values of NFs and GDF15 were analyzed initial while the values of CRP and NLR were analyzed initial and after two years.&#x0D; Results: We found statistically lower GDF15 values and initial CRP values in MS group in regards to group with non-inflammatory diseases of the CNS (p=0.000). On the other side, we determined significant elevation of laboratory markers CRP and NLR, initial and after two years period, in MS subgroup with progression of MRI findings (p= 0.000 and p=0.050, respectively). Also we found a positive correlation of CRP and neurofilaments (r=0.243, p=0.04), as well as a positive correlation of CRP and GDF15 in patients with MS (r=0.769, p=0.000).&#x0D; Conclusion: We found significant elevation of laboratory markers of systemic inflammation, CRP and NLR in MS patients who developed disease progression based on MRI findings.&#x0D; Key words: Multiple sclerosis; Neutrophil to lymphocyte ratio; C reactive protein, Neurofilaments, Growth differentiation factor 15","PeriodicalId":16175,"journal":{"name":"Journal of Medical Biochemistry","volume":"17 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135615987","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Expression levels and diagnostic value of serum GDNF, CEA and CA199 in patients with Colorectal Carcinoma 结直肠癌患者血清GDNF、CEA、CA199的表达水平及诊断价值
4区 医学 Q4 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2023-10-03 DOI: 10.5937/jomb0-44745
Jue Wang, Lulu Liu, Yan Zheng, Sai Gu
Background: To investigate the expression levels and diagnostic value of glial cell line-derived neurotrophic factor (GDNF), carcinoembryonic antigen (CEA) and carbohydrate antigen199 (CA199) in patients with colorectal carcinoma (CRC). Methods. 50 CRC patients at our hospital from Feb. 2020 to Feb. 2021 were chosen as the malignant group, another 50 patients with benign colonic diseases were chosen as the benign group, and 50 healthy people who came to our hospital for physical examination during the same period were considered as the control group. Fasting peripheral venous blood was taken from all research subjects in the morning and tested by a fully-automated electrochemiluminometer to determine the GDNF, CEA and CA199 levels. The sensitivity and specificity of the combined detection of the three indexes for CRC were analyzed, and the ROC curve was plotted to record the area under the curve (AUC). Results. The malignant group had remarkably higher CEA and CA199 levels (P<0.001) and a lower GDNF level (P<0.001) when compared with the benign and control groups. The sensitivity, specificity, positive predictive value and negative predictive value of the combined detection were 96.0%, 94.0%, 88.9% and 97.9%, respectively. The combined detection had the AUC (95% CI) = 0.950 (0.909-0.991), the standard error of 0.021, and the progressive Sig.b<0.001. Conclusion. The combined diagnosis of serum GDNF, CEA and CA199 is a reliable method to improve the diagnostic accuracy of CRC, and this strategy can effectively reduce the missed diagnosis rate and has high application value in clinic.
背景:探讨胶质细胞系源性神经营养因子(GDNF)、癌胚抗原(CEA)和碳水化合物抗原199 (CA199)在结直肠癌(CRC)患者中的表达水平及诊断价值。& # x0D;方法:选取2020年2月至2021年2月在我院就诊的结直肠癌患者50例为恶性组,结肠良性疾病患者50例为良性组,同期来我院体检的健康人50例为对照组。所有研究对象于早晨空腹外周静脉血,采用全自动电化学发光仪检测GDNF、CEA和CA199水平。分析3项指标联合检测CRC的敏感性和特异性,绘制ROC曲线,记录曲线下面积(AUC)。& # x0D;结果。与良性组和对照组相比,恶性组CEA和CA199水平显著升高(P<0.001), GDNF水平显著降低(P<0.001)。联合检测的敏感性、特异性、阳性预测值和阴性预测值分别为96.0%、94.0%、88.9%和97.9%。联合检测的AUC (95% CI) = 0.950(0.909 ~ 0.991),标准误差为0.021,渐进式Sig.b<0.001。& # x0D;结论。血清GDNF、CEA、CA199联合诊断是提高结直肠癌诊断准确率的可靠方法,该策略可有效降低漏诊率,具有较高的临床应用价值。
{"title":"Expression levels and diagnostic value of serum GDNF, CEA and CA199 in patients with Colorectal Carcinoma","authors":"Jue Wang, Lulu Liu, Yan Zheng, Sai Gu","doi":"10.5937/jomb0-44745","DOIUrl":"https://doi.org/10.5937/jomb0-44745","url":null,"abstract":"Background: To investigate the expression levels and diagnostic value of glial cell line-derived neurotrophic factor (GDNF), carcinoembryonic antigen (CEA) and carbohydrate antigen199 (CA199) in patients with colorectal carcinoma (CRC). &#x0D; Methods. 50 CRC patients at our hospital from Feb. 2020 to Feb. 2021 were chosen as the malignant group, another 50 patients with benign colonic diseases were chosen as the benign group, and 50 healthy people who came to our hospital for physical examination during the same period were considered as the control group. Fasting peripheral venous blood was taken from all research subjects in the morning and tested by a fully-automated electrochemiluminometer to determine the GDNF, CEA and CA199 levels. The sensitivity and specificity of the combined detection of the three indexes for CRC were analyzed, and the ROC curve was plotted to record the area under the curve (AUC). &#x0D; Results. The malignant group had remarkably higher CEA and CA199 levels (P<0.001) and a lower GDNF level (P<0.001) when compared with the benign and control groups. The sensitivity, specificity, positive predictive value and negative predictive value of the combined detection were 96.0%, 94.0%, 88.9% and 97.9%, respectively. The combined detection had the AUC (95% CI) = 0.950 (0.909-0.991), the standard error of 0.021, and the progressive Sig.b<0.001. &#x0D; Conclusion. The combined diagnosis of serum GDNF, CEA and CA199 is a reliable method to improve the diagnostic accuracy of CRC, and this strategy can effectively reduce the missed diagnosis rate and has high application value in clinic.","PeriodicalId":16175,"journal":{"name":"Journal of Medical Biochemistry","volume":"8 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135739483","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Expression and clinical significance of CA125, CA153 and CEA in nipple discharge of breast cancer patients 乳腺癌患者乳头溢液中CA125、CA153、CEA的表达及临床意义
4区 医学 Q4 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2023-09-20 DOI: 10.5937/jomb0-45192
Jun Geng, Jinli Shi, Weina Guo, Haiyan Li, Dan Yang, Yan Gao
Background: It is an important clinical means to identify benign and malignant breast diseases caused by nipple discharge through the detection and analysis of components in nipple discharge. This study was aimed to test the expression and clinical significance of carbohydrate antigen 125 (CA125), carbohydrate antigen 153 (CA153) and carcinoembryonic antigen (CEA) in nipple discharge of breast cancer patients. Methods: From January 2017 to December 2018, 86 patients with invasive ductal carcinoma of the breast with nipple discharge (breast cancer group) and 50 patients with ordinary breast duct hyperplasia with nipple discharge (benign control group) were selected, and the nipple discharge and serum CA125, CA153 and CEA levels in the two groups were detected by electrochemiluminescence immunoassay. Results: The nipple discharge and serum CA125, CA153 and CEA levels in the benign control group were significantly lower than those in the breast cancer group, and the serum CA125, CA153 and CEA levels were obviously lower than those nipple discharge levels. The expression levels of CA125, CA153 and CEA in nipple discharge in the breast cancer group had no significant difference in different age of onset and different tumor sites. The CA125, CA153 and CEA levels in nipple discharge of patients with tumor diameter n5 cm, low differentiation, high stage, metastasis, and recurrence were obviously elevated versus to those of patients with tumor diameter <5 cm, high differentiation, low stage, and no metastasis and recurrence. These levels were not significantly correlated with the expression of estrogen receptor (ER) and progesterone receptor (PR), but was significantly correlated with the expression of human epidermal growth factor receptor (HER-2) and Ki-67. The accuracy, sensitivity, and negative predictive value of nipple discharge CA125, CA153 and CEA combined tests in the diagnosis of breast cancer were markedly improved compared with serum combinations and individual tests. Conclusion: The combination of CA125, CA153 and CEA in nipple discharge can be considered as a potential diagnostic method for breast cancer, which is an effective supplement to serological diagnosis, and can provide new ideas for the differential diagnosis of benign and malignant breast cancer with nipple discharge.
背景:通过对乳头溢液成分的检测和分析,是鉴别乳头溢液引起的乳腺良恶性疾病的重要临床手段。本研究旨在检测乳腺癌患者乳头溢液中碳水化合物抗原125 (CA125)、碳水化合物抗原153 (CA153)和癌胚抗原(CEA)的表达及其临床意义。& # x0D;方法:选取2017年1月~ 2018年12月86例浸润性乳腺导管癌伴乳头溢液患者(乳腺癌组)和50例普通乳腺导管增生伴乳头溢液患者(良性对照组),采用电化学发光免疫分析法检测两组患者乳头溢液及血清CA125、CA153、CEA水平。结果:良性对照组乳头溢液及血清CA125、CA153、CEA水平显著低于乳腺癌组,血清CA125、CA153、CEA水平明显低于乳腺癌组。乳腺癌组乳头溢液中CA125、CA153、CEA的表达水平在不同发病年龄、不同肿瘤部位差异无统计学意义。肿瘤直径为n5 cm、低分化、高分期、转移、复发患者乳头溢液中CA125、CA153、CEA水平明显高于肿瘤直径为n5 cm、高分化、低分期、无转移、复发患者。这些水平与雌激素受体(ER)和孕激素受体(PR)的表达不显著相关,但与人表皮生长因子受体(HER-2)和Ki-67的表达显著相关。乳头溢液CA125、CA153、CEA联合检测诊断乳腺癌的准确性、敏感性及阴性预测值均较血清联合检测及单项检测明显提高。 结论:乳头溢液中CA125、CA153、CEA联合检测可视为乳腺癌的潜在诊断方法,是血清学诊断的有效补充,可为乳头溢液良恶性乳腺癌的鉴别诊断提供新思路。
{"title":"Expression and clinical significance of CA125, CA153 and CEA in nipple discharge of breast cancer patients","authors":"Jun Geng, Jinli Shi, Weina Guo, Haiyan Li, Dan Yang, Yan Gao","doi":"10.5937/jomb0-45192","DOIUrl":"https://doi.org/10.5937/jomb0-45192","url":null,"abstract":"Background: It is an important clinical means to identify benign and malignant breast diseases caused by nipple discharge through the detection and analysis of components in nipple discharge. This study was aimed to test the expression and clinical significance of carbohydrate antigen 125 (CA125), carbohydrate antigen 153 (CA153) and carcinoembryonic antigen (CEA) in nipple discharge of breast cancer patients. &#x0D; Methods: From January 2017 to December 2018, 86 patients with invasive ductal carcinoma of the breast with nipple discharge (breast cancer group) and 50 patients with ordinary breast duct hyperplasia with nipple discharge (benign control group) were selected, and the nipple discharge and serum CA125, CA153 and CEA levels in the two groups were detected by electrochemiluminescence immunoassay.&#x0D; Results: The nipple discharge and serum CA125, CA153 and CEA levels in the benign control group were significantly lower than those in the breast cancer group, and the serum CA125, CA153 and CEA levels were obviously lower than those nipple discharge levels. The expression levels of CA125, CA153 and CEA in nipple discharge in the breast cancer group had no significant difference in different age of onset and different tumor sites. The CA125, CA153 and CEA levels in nipple discharge of patients with tumor diameter n5 cm, low differentiation, high stage, metastasis, and recurrence were obviously elevated versus to those of patients with tumor diameter <5 cm, high differentiation, low stage, and no metastasis and recurrence. These levels were not significantly correlated with the expression of estrogen receptor (ER) and progesterone receptor (PR), but was significantly correlated with the expression of human epidermal growth factor receptor (HER-2) and Ki-67. The accuracy, sensitivity, and negative predictive value of nipple discharge CA125, CA153 and CEA combined tests in the diagnosis of breast cancer were markedly improved compared with serum combinations and individual tests.&#x0D; Conclusion: The combination of CA125, CA153 and CEA in nipple discharge can be considered as a potential diagnostic method for breast cancer, which is an effective supplement to serological diagnosis, and can provide new ideas for the differential diagnosis of benign and malignant breast cancer with nipple discharge.","PeriodicalId":16175,"journal":{"name":"Journal of Medical Biochemistry","volume":"37 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136308928","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
YAP drives the development of cardiovascular disease in patients with rheumatoid arthritis YAP驱动类风湿关节炎患者心血管疾病的发展
4区 医学 Q4 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2023-09-20 DOI: 10.5937/jomb0-45932
Guozhu Che, Ying Liu, Na Zhang, Jing Zhao
Background: To assess the influence of serum level of YAP on laboratory examination findings, imaging findings and disease activity of rheumatoid arthritis patients combined cardiovascular disease (RA-CVD). Methods: RA-CVD patients (n=60), RA-nCVD patients (n=60) and healthy subjects (n=60) were recruited. Serum levels of YAP in them were detected by qRT-PCR. Their baseline characteristics were analyzed and compared. Disease activity, CVD risk factors and imaging findings in RA-CVD and RA-nCVD patients were evaluated and compared. In addition, potential influences of YAP on disease activity, CVD risk factors and imaging findings in RA-CVD patients were assessed. Results: RA-CVD patients had higher levels of ERS, anti-CCP, RF, HDL-C, CRP, FRS, BNP, LA, LVs, LVd and cIMT, and lower level of EF in comparison to RA-nCVD patients. Serum level of YAP was higher in RA-CVD patients than that of RA-nCVD patients and healthy subjects. YAP level was positively correlated to DAS28, TG, CRP, PLT, FRS, BNP and cIMT in RA-CVD patients. Conclusion: Serum level of YAP increases in RA-CVD patients. YAP is a potential factor driving the development of CVD in RA patients through regulating inflammatory response, lipid metabolism, glycometabolism and thrombosis.
背景:探讨血清YAP水平对类风湿关节炎合并心血管疾病(RA-CVD)患者实验室检查、影像学表现及疾病活动度的影响。& # x0D;方法:招募RA-CVD患者(n=60)、RA-nCVD患者(n=60)和健康受试者(n=60)。采用qRT-PCR检测各组血清YAP水平。分析比较他们的基线特征。对RA-CVD和RA-nCVD患者的疾病活动性、CVD危险因素和影像学表现进行评价和比较。此外,还评估了YAP对RA-CVD患者疾病活动性、CVD危险因素和影像学表现的潜在影响。& # x0D;结果:RA-CVD患者的ERS、anti-CCP、RF、HDL-C、CRP、FRS、BNP、LA、lv、LVd和cIMT水平均高于RA-nCVD患者,EF水平低于RA-nCVD患者。RA-CVD患者血清YAP水平高于RA-nCVD患者和健康人。RA-CVD患者的YAP水平与DAS28、TG、CRP、PLT、FRS、BNP、cIMT呈正相关。& # x0D;结论:RA-CVD患者血清YAP水平升高。YAP通过调节炎症反应、脂质代谢、糖代谢和血栓形成,是推动RA患者CVD发展的潜在因素。
{"title":"YAP drives the development of cardiovascular disease in patients with rheumatoid arthritis","authors":"Guozhu Che, Ying Liu, Na Zhang, Jing Zhao","doi":"10.5937/jomb0-45932","DOIUrl":"https://doi.org/10.5937/jomb0-45932","url":null,"abstract":"Background: To assess the influence of serum level of YAP on laboratory examination findings, imaging findings and disease activity of rheumatoid arthritis patients combined cardiovascular disease (RA-CVD). &#x0D; Methods: RA-CVD patients (n=60), RA-nCVD patients (n=60) and healthy subjects (n=60) were recruited. Serum levels of YAP in them were detected by qRT-PCR. Their baseline characteristics were analyzed and compared. Disease activity, CVD risk factors and imaging findings in RA-CVD and RA-nCVD patients were evaluated and compared. In addition, potential influences of YAP on disease activity, CVD risk factors and imaging findings in RA-CVD patients were assessed. &#x0D; Results: RA-CVD patients had higher levels of ERS, anti-CCP, RF, HDL-C, CRP, FRS, BNP, LA, LVs, LVd and cIMT, and lower level of EF in comparison to RA-nCVD patients. Serum level of YAP was higher in RA-CVD patients than that of RA-nCVD patients and healthy subjects. YAP level was positively correlated to DAS28, TG, CRP, PLT, FRS, BNP and cIMT in RA-CVD patients. &#x0D; Conclusion: Serum level of YAP increases in RA-CVD patients. YAP is a potential factor driving the development of CVD in RA patients through regulating inflammatory response, lipid metabolism, glycometabolism and thrombosis.","PeriodicalId":16175,"journal":{"name":"Journal of Medical Biochemistry","volume":"28 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136309098","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical observation of laparoscopic sleeve gastrectomy and metformin treatment in obese PCOS patients 腹腔镜套筒胃切除术联合二甲双胍治疗肥胖型多囊卵巢综合征的临床观察
4区 医学 Q4 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2023-09-13 DOI: 10.5937/jomb0-44411
Qingya Ma, Xiaojing He, Zijie Fu, Xiaodong Ren, Ranran Sun, Siqi Zhu, Xiaodong Li, Yahui Bian
Background: to observe the basic metabolic characteristics of obese patients with PCOS, and observe and compare the effect of laparoscopic sleeve gastrectomy and metformin treatment after 3 months. Methods: In January to December 2018, the Second Hospital of Hebei Medical University selected 104 women who were classified as obese with a BMI of 28kg/cm2 or higher and had PCOS. They were divided into obese PCOS group (53 cases) and obese non-pcos group (51 cases). Results: 1. There was no significant difference in waist circumference and WHR between patients who are obese with PCOS and patients who are obese without PCOS (P > 0.05).Obese PCOS patients were significantly higher in AMH, LH/FSH, T, FAI, homa-ir, TG, LDL, apo-b and uric acid than the group of non-PCOS patients who were obese. (P<0.05). The SHBG levels of obese patients with PCOS were obviously lower when contrasted with the levels in obese patients without PCOS (P < 0.05). 2. Body weight, BMI, INS, homa-ir and TG of obese PCOS patients were significantly decreased 3 months after laparoscopic sleeve gastrectomy compared with that before surgery (P < 0.05). After three months of medical treatment with metformin, the patients' HOMA-IR was obviously reduced when contrasted with the pre-treatment HOMA-IR levels (P < 0.05), and there was no significant difference in the improvement degree of homa-ir between the two groups (P > 0.05). Conclusion: 1. Obese patients with PCOS demonstrated higher expression of AMH, LH/FSH, T, SHBG, and FAI when contrasted with the control group. Additionally, they experienced more severe insulin resistance and lipid metabolism disorders. 2. The weight and BMI of obese PCOS patients were significantly decreased after weight loss, while IR and blood lipid were significantly improved, while IR was improved in metformin group, and no significant discrepancy was observed in the degree of improvement of insulin resistance between both groups.
背景:观察肥胖多囊卵巢综合征患者的基本代谢特征,并观察比较3个月后腹腔镜袖式胃切除术与二甲双胍治疗的效果。 方法:2018年1 - 12月,河北医科大学第二医院选取BMI为28kg/cm2及以上的肥胖女性104例。分为肥胖多囊卵巢综合征组(53例)和肥胖非多囊卵巢综合征组(51例)。结果:1。肥胖合并多囊卵巢综合征患者与肥胖无多囊卵巢综合征患者的腰围和腰宽比无显著差异(P >0.05)。肥胖PCOS患者AMH、LH/FSH、T、FAI、homa-ir、TG、LDL、apo-b、尿酸均显著高于肥胖非PCOS患者组。术中,0.05)。肥胖多囊卵巢综合征患者的SHBG水平明显低于肥胖无多囊卵巢综合征患者(P <0.05)。2. 肥胖型多囊卵巢综合征(PCOS)患者在腹腔镜袖胃切除术后3个月的体重、BMI、INS、homa-ir和TG均较术前显著降低(P <0.05)。经二甲双胍治疗3个月后,患者HOMA-IR较治疗前明显降低(P <0.05),两组患者homa-ir改善程度差异无统计学意义(P >0.05)强生# x0D;结论:1。与对照组相比,肥胖多囊卵巢综合征患者AMH、LH/FSH、T、SHBG和FAI的表达更高。此外,他们经历了更严重的胰岛素抵抗和脂质代谢紊乱。2. 肥胖PCOS患者减肥后体重、BMI均明显下降,IR、血脂均明显改善,而二甲双胍组IR有所改善,两组胰岛素抵抗改善程度无显著差异。
{"title":"Clinical observation of laparoscopic sleeve gastrectomy and metformin treatment in obese PCOS patients","authors":"Qingya Ma, Xiaojing He, Zijie Fu, Xiaodong Ren, Ranran Sun, Siqi Zhu, Xiaodong Li, Yahui Bian","doi":"10.5937/jomb0-44411","DOIUrl":"https://doi.org/10.5937/jomb0-44411","url":null,"abstract":"Background: to observe the basic metabolic characteristics of obese patients with PCOS, and observe and compare the effect of laparoscopic sleeve gastrectomy and metformin treatment after 3 months.&#x0D; Methods: In January to December 2018, the Second Hospital of Hebei Medical University selected 104 women who were classified as obese with a BMI of 28kg/cm2 or higher and had PCOS. They were divided into obese PCOS group (53 cases) and obese non-pcos group (51 cases).&#x0D; Results: 1. There was no significant difference in waist circumference and WHR between patients who are obese with PCOS and patients who are obese without PCOS (P > 0.05).Obese PCOS patients were significantly higher in AMH, LH/FSH, T, FAI, homa-ir, TG, LDL, apo-b and uric acid than the group of non-PCOS patients who were obese. (P<0.05). The SHBG levels of obese patients with PCOS were obviously lower when contrasted with the levels in obese patients without PCOS (P < 0.05). 2. Body weight, BMI, INS, homa-ir and TG of obese PCOS patients were significantly decreased 3 months after laparoscopic sleeve gastrectomy compared with that before surgery (P < 0.05). After three months of medical treatment with metformin, the patients' HOMA-IR was obviously reduced when contrasted with the pre-treatment HOMA-IR levels (P < 0.05), and there was no significant difference in the improvement degree of homa-ir between the two groups (P > 0.05).&#x0D; Conclusion: 1. Obese patients with PCOS demonstrated higher expression of AMH, LH/FSH, T, SHBG, and FAI when contrasted with the control group. Additionally, they experienced more severe insulin resistance and lipid metabolism disorders. 2. The weight and BMI of obese PCOS patients were significantly decreased after weight loss, while IR and blood lipid were significantly improved, while IR was improved in metformin group, and no significant discrepancy was observed in the degree of improvement of insulin resistance between both groups.","PeriodicalId":16175,"journal":{"name":"Journal of Medical Biochemistry","volume":"11 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135785789","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Medical Biochemistry
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1